GlassScriptPhysician profile
Dale W Drollinger
NPI 1679598734
$2,043.94
in general payments reported to CMS, 2019-2025
23 companies · $132 in 2025
The $132 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $246 · 2020: $254 · 2021: $482 · 2022: $489 · 2023: $261 · 2024: $180 · 2025: $132.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $560 · Education: $13.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $559.89 |
| Education | $13.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $453.28 | 2019-2024 | Slynd, Tyblume |
| Abbvie INC. | $301.87 | 2019-2025 | Orilissa, Lo Loestrin Fe |
| Avion Pharmaceuticals | $181.22 | 2020-2022 | |
| Myovant Sciences INC. | $149.40 | 2021-2022 | |
| Novo Nordisk INC | $135.32 | 2019-2024 | Wegovy |
| Organon LLC | $125.82 | 2021-2025 | Nexplanon |
| Medicem INC. | $98.11 | 2022 | |
| Pfizer INC. | $96.06 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $76.56 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $75.76 | 2019-2021 | |
| Shield Therapeutics INC | $58.00 | 2024-2025 | |
| Therapeuticsmd, INC. | $52.10 | 2019-2020 | |
| Biogen, INC. | $40.03 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $32.28 | 2019-2025 | Paragard T 380a |
| Agile Therapeutics, INC. | $30.37 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.56 | 2019-2020 | |
| Mission Pharmacal Company | $24.46 | 2019-2021 | |
| Eisai INC. | $18.31 | 2019 | |
| Currax Pharmaceuticals LLC | $15.84 | 2024 | Contrave |
| Astellas Pharma US INC | $13.36 | 2019 | |
| Millicent US INC | $13.35 | 2024 | |
| Hologic Sales and Service, LLC | $13.29 | 2019 | |
| Virtus Pharmaceuticals LLC | $12.59 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dale Drollinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.